| Type | Title | Date Released | |
|---|---|---|---|
6-K | BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026 | ||
6-K | BioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness and CDMO Licensing | ||
6-K | Tate & Lyle and BioHarvest Reach Key Milestone in Next-Generation Sweetener Development Programme | ||
6-K | BioHarvest Sciences Announces Share Repurchase Program | ||
6-K | BioHarvest Sciences Inc. Achieves Dual-Listing on the Tel Aviv Stock Exchange | ||
6-K | BioHarvest Sciences Launches Single-Dose VINIA® Daily Chews to Expand Botanical Synthesis Product Portfolio | ||
6-K | BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference | ||
6-K | BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) | ||
6-K | BioHarvest Reports Q2 2026 Financial Results and Secures First CDMO Manufacturing Agreement | ||
6-K | BioHarvest Sciences Inc. Reports Unaudited Financial Results for the Second Quarter and Six Months Ended June 30, 2026 | ||
6-K | BioHarvest Sciences CEO Zaki Rakib to Present at Canaccord Genuity 46th Annual Growth Conference | ||
6-K | BioHarvest Sciences to Report Second Quarter 2026 Financial Results |
